Akari Therapeutics (AKTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.18
0.03 (2.61%)
At close: Jan 15, 2025, 10:58 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
PE Ratio | -1.53 | -4.21 | -3.66 | -3.32 | -1.47 | -24.88 | -39.22 | -91.41 | -54.53 | -85.09 | -93.15 | -138.91 | -100.95 | -316.91 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -66.68 | 16.39 | 11.59 | 4.72 | 8.35 | 37.11 | 54.81 | 48.62 | 50.72 | 169.16 | 58.00 | -59.33 | -86.08 | n/a |
P/FCF Ratio | -0.93 | -1.36 | -3.42 | -3.45 | -2.61 | -22.02 | -34.62 | -67.19 | -496.58 | -86.25 | -61.87 | -93.59 | -212.22 | -584.47 |
P/OCF Ratio | -0.93 | -1.36 | -3.42 | -3.45 | -2.61 | -22.02 | -34.66 | -67.34 | -497.64 | -86.77 | -61.87 | -93.41 | -212.22 | -584.47 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | -0.27 | n/a | n/a |
Quick Ratio | 0.95 | 1.35 | 1.91 | 3.47 | 2.07 | 5.98 | 3.19 | 3.90 | 3.30 | 4.73 | 6.36 | 0.29 | 0.01 | n/a |
Current Ratio | 0.95 | 1.15 | 1.91 | 3.37 | 1.88 | 5.33 | 3.19 | 3.90 | 3.30 | 4.73 | 6.36 | 0.29 | 0.01 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.98 | -10.01 | n/a | -17.85 | -3.52 | n/a | -158.4 |
Return on Equity (ROE) | 43.70 | -3.89 | -3.17 | -1.42 | -5.67 | -1.49 | -1.4 | -0.53 | -0.93 | -1.99 | -0.62 | 0.43 | 0.85 | n/a |
Return on Assets (ROA) | -2.3 | -0.5 | -1.51 | -1 | -2.11 | -1.21 | -0.96 | -0.4 | -0.65 | -1.49 | -0.46 | -1.28 | -78.48 | n/a |
Return on Capital (ROIC) | 73.39 | -12.89 | -3.1 | -1.45 | -5.13 | -1.49 | -1.75 | -0.8 | -0.63 | -1.99 | -0.55 | 1.34 | 1.02 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |